Volpara Health Enters Agreement to be Acquired by Lunit, Inc.

Volpara Health Technologies (Volpara), a global leader in software for the early detection of breast cancer, is pleased to announce it has entered into an agreement to be acquired by Lunit Inc. Under the terms of the agreement, Lunit would acquire all shares of Volpara stock for A$1.15 per share in cash, representing a 47.4% premium to the Company’s closing stock price on December 13, 2023. The transaction is expected to accelerate Volpara’s ability to serve its purpose of saving families from cancer. With the support of Lunit’s in-house radiologists and complementary technologies, Volpara’s repository of more than 100 million images would be strategically augmented by additional AI expertise and solutions.  Together the companies plan to explore new opportunities in global markets and offer a broader portfolio of products in Volpara’s largest market, the US. CEO and Managing Director at Volpara, Teri Thomas, said, “Lunit’s interest in acquiring Volpara is a strong testament to the high quality of our products, our significant US market presence, and the hard work of our employees. Working together, Lunit and Volpara would have the opportunity to develop products that very few companies are in a position to do. This is expected to put us at the forefront of cancer technology and position us as a global leader in our field.” The offer will be implemented by way of a scheme of arrangement (Scheme), a common process for acquisi...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Health IT Company Healthcare IT Health IT Acquisitions Healthcare M&A Lunit Lunit Inc. Teri Thomas Volpara Volpara Health Technologies Source Type: blogs